I agree that this site is using cookies. You can find further informations here.
X
Hitz, F.
168  results:
Search for persons X
?
1

SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN P..:

Stathis, A. ; Hitz, F. ; Schär, S....
Hematological Oncology.  41 (2023)  S2 - p. 165-166 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Mature T and NK cell lymphomas classified according to 2016..:

Manni, M. ; Chiattone, C. S. ; Prince, M. H....
Hematological Oncology.  41 (2023)  S2 - p. 311-312 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Baseline PET Total Metabolic Tumor Volume has a prognostic ..:

Skrypets, T. ; Chauvie, S. ; Manni, M....
Hematological Oncology.  41 (2023)  S2 - p. 349-349 , 2023
Link: https://doi.org/10.1002/..
 
?
4

SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IB..:

Østenstad, B. ; Pirosa, M. C. ; Schär, S....
Hematological Oncology.  41 (2023)  S2 - p. 117-119 , 2023
Link: https://doi.org/10.1002/..
 
?
5

S222: MATURE T AND NK CELL LYMPHOMAS CLASSIFIED ACCORDING T..:

Federico, M. ; Stepanishyna, Y. ; Skrypets, T....
HemaSphere.  6 (2022)  - p. 123-124 , 2022
Link: https://doi.org/10.1097/..
 
?
6

Clinical characteristics and outcome of patients over 60 ye..:

Moccia, A. A. ; Aeppli, S. ; Güsewell, S....
Hematological Oncology.  39 (2020)  2 - p. 196-204 , 2020
Link: https://doi.org/10.1002/..
 
?
7

Nelfinavir and lenalidomide/dexamethasone in patients with ..:

Hitz, F. ; Kraus, M. ; Pabst, T....
Blood Cancer Journal.  9 (2019)  9 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
8

SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION ..:

Stathis, A. ; Mey, U. ; Schär, S....
Hematological Oncology.  37 (2019)  S2 - p. 118-119 , 2019
Link: https://doi.org/10.1002/..
 
?
9

CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HODGK..:

Aeppli, S. ; Moccia, A. ; Bargetzi, M....
Hematological Oncology.  37 (2019)  S2 - p. 289-290 , 2019
Link: https://doi.org/10.1002/..
 
?
10

PROGNOSTIC IMPLICATIONS OF THE MICROENVIRONMENT IN FOLLICUL..:

Menter, T. ; Tzankov, A. ; Zucca, E....
Hematological Oncology.  37 (2019)  S2 - p. 149-151 , 2019
Link: https://doi.org/10.1002/..
 
?
11

IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA‐NODAL NK..:

Fox, C.P. ; Bellei, M. ; Manni, M....
Hematological Oncology.  35 (2017)  S2 - p. 78-79 , 2017
Link: https://doi.org/10.1002/..
 
?
12

Erlotinib has comparable clinical efficacy to chemotherapy ..:

Neumair, P. ; Joos, L. ; Warschkow, R....
Lung Cancer.  100 (2016)  - p. 38-44 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Diffuse large B-cell lymphoma in elderly patients: A retros..:

Diem, S. ; Ess, S. ; Cerny, Th...
European Journal of Internal Medicine.  25 (2014)  6 - p. 577-582 , 2014
Link: https://doi.org/10.1016/..
 
?
14

80P MANAGEMENT OF ELDERLY PATIENTS WITH ADVANCED NON-SMALL ..:

Früh, M. ; Besrour, H. ; Gillessen, S....
Lung Cancer.  80 (2013)  - p. S36 , 2013
Link: https://doi.org/10.1016/..
 
?
15

Safety and pharmacology of gemcitabine and capecitabine in ..:

Joerger, M. ; Huitema, A. D. R. ; Koeberle, D....
Cancer Chemotherapy and Pharmacology.  73 (2013)  1 - p. 113-124 , 2013
Link: https://doi.org/10.1007/..
 
1-15